Intracystic papillary carcinoma of the breast: An in situ or invasive tumor? results of immunohistochemical analysis and clinical follow-up

American Journal of Surgical Pathology

Volumn 35, Issue 1, 2011, Pages 1-14

  Wynveen, Christine A ^a   Nehhozina, Tatjana ^a   Akram, Muzaffar ^a   Hassan, Mohammed ^a   Norton, Larry ^a   Van Zee, Kimberly J ^a   Brogi, Edi ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

basement membrane; collagen IV; encapsulated papillary carcinoma; intraductal papillary carcinoma; myoepithelium

Indexed keywords

COLLAGEN TYPE 4; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; HER2 PROTEIN, HUMAN; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; CANCER INVASION; CARCINOMA IN SITU; CHEMISTRY; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; MASTECTOMY; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; SEGMENTAL MASTECTOMY; TIME; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA IN SITU; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; COLLAGEN TYPE IV; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEW YORK CITY; RADIOTHERAPY, ADJUVANT; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 78650888644     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181fbe20a     Document Type: Article

References (29)

1. Calderaro J, Espie M, Duclos J, et al. Breast intracystic papillary carcinoma: an update. Breast J. 2009;15:639-644.
2. Carter D. Intraductal papillary tumors of the breast: a study of 78 cases. Cancer. 1977;39:1689-1692.
3. Carter D, Orr SL, Merino MJ. Intracystic papillary carcinoma of the breast: after mastectomy, radiotherapy or excisional biopsy alone. Cancer. 1983;52:14-19.
4. Collins LC, Carlo VP, Hwang H, et al. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006;30:1002-1007.
5. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology. 1991;19:403-410.
6. Esposito NN, Dabbs DJ, Bhargava R. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases. Am J Clin Pathol. 2009;131:228-242.
7. Fayanju OM, Ritter J, Gillanders WE, et al. Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy. Am J Surg. 2007;194:497-500.
8. Harris KP, Faliakou EC, Exon DJ, et al. Treatment and outcome of intracystic papillary carcinoma of the breast. Br J Surg. 1999; 86:1274.
9. Hill CB, Yeh IT. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol. 2005;123:36-44.
10. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications. Am J Surg Pathol. 2009;33:227-232.
11. Ibarra JA. Papillary lesions of the breast. Breast J. 2006;12:237-251.
12. Imoto S, Hasebe T. Intracystic papillary carcinoma of the breast in male: case report and review of the Japanese literature. Jpn J Clin Oncol. 1998;28:517-520.
13. Inoue S, Kunitomo K, Okamoto H, et al. A case of male noninvasive intracystic papillary carcinoma forming a tumor in the nipple duct. Breast Cancer. 2003;10:85-88.
14. Kihara M, Mori N, Yamauchi A, et al. A case of intracystic papillary carcinoma with a multilocular cyst of the breast in male. Breast Cancer. 2004;11:409-412.
15. Kinoshita T, Fukutomi T, Iwamoto E, et al. Intracystic papillary carcinoma of the breast in a male patient diagnosed by core needle biopsy: a case report. Breast. 2005;14:322-324.
16. Leal C, Costa I, Fonseca D, et al. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study. Hum Pathol. 1998;29:1097-1104.
17. Lefkowitz M, Lefkowitz W, Wargotz ES. Intraductal (intracystic) papillary carcinoma of the breast and its variants: a clinicopathological study of 77 cases. Hum Pathol. 1994;25:802-809.
18. Lerwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol. 2004;28: 1076-1091.
19. Maatta M, Virtanen I, Burgeson R, et al. Comparative analysis of the distribution of laminin chains in the basement membranes in some malignant epithelial tumors: the alpha1 chain of laminin shows a selected expression pattern in human carcinomas. J Histochem Cytochem. 2001;49:711-726.
20. MacGrogan F, Moinfar F, Raju U. Intraductal papillary neoplasms. In: Tavassoli F, Devilee P, eds. World Health Organization Classification of Tumours Pathology & Genetics of Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003:76-80.
21. Mulligan AM, O'Malley FP. Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases. Int J Surg Pathol. 2007;15:143-147.
22. Nerlich AG, Lebeau A, Hagedorn HG, et al. Morphological aspects of altered basement membrane metabolism in invasive carcinomas of the breast and the larynx. Anticancer Res. 1998;18:3515-3520.
23. Raymond WA, Leong AS. Assessment of invasion in breast lesions using antibodies to basement membrane components and myoepithelial cells. Pathology. 1991;23:291-297.
24. Romics L Jr, O'Brien ME, Relihan N, et al. Intracystic papillary carcinoma in a male as a rare presentation of breast cancer: a case report and literature review. J Med Case Reports. 2009;3:13.
25. Solorzano CC, Middleton LP, Hunt KK, et al. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg. 2002;184:364-368.
26. Visscher DW, Sarkar FH, Sakr W, et al. Immunohistologic analysis of invasive phenotype in breast carcinoma: a clinicopathologic study. Pathol Res Pract. 1993;189:867-872.
27. Wolff AC, Hammond ME, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25:118-145.
28. Yamamoto H, Okada Y, Taniguchi H, et al. Intracystic papilloma in the breast of a male given long-term phenothiazine therapy: a case report. Breast Cancer. 2006;13:84-88.
29. Yoshida M, Mouri Y, Yamamoto S, et al. Intracystic invasive papillary carcinoma of the male breast with analyses of loss of heterozygosity on chromosome 16q. Breast Cancer. 2010;17: 146-150.